353 related articles for article (PubMed ID: 30680153)
1. Assessing the social cost and benefits of a national requirement establishing antibiotic stewardship programs to prevent
Scott RD; Slayton RB; Lessa FC; Baggs J; Culler SD; McDonald LC; Jernigan JA
Antimicrob Resist Infect Control; 2019; 8():17. PubMed ID: 30680153
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Economic Benefits of Antimicrobial Stewardship Programs in Hemodialysis Facilities: A Decision Analytic Model.
D'Agata EMC; Tran D; Bautista J; Shemin D; Grima D
Clin J Am Soc Nephrol; 2018 Sep; 13(9):1389-1397. PubMed ID: 30139804
[TBL] [Abstract][Full Text] [Related]
3. Clostridioides difficile Infection in Children: The Role of Infection Prevention and Antimicrobial Stewardship.
Savage TJ; Sandora TJ
J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S64-S68. PubMed ID: 34791402
[TBL] [Abstract][Full Text] [Related]
4. Prevention of Infection due to Clostridium (Clostridioides) difficile.
Krishna A; Chopra T
Infect Dis Clin North Am; 2021 Dec; 35(4):995-1011. PubMed ID: 34752229
[TBL] [Abstract][Full Text] [Related]
5. Association of a Safety Program for Improving Antibiotic Use With Antibiotic Use and Hospital-Onset Clostridioides difficile Infection Rates Among US Hospitals.
Tamma PD; Miller MA; Dullabh P; Ahn R; Speck K; Gao Y; Scherpf E; Cosgrove SE
JAMA Netw Open; 2021 Feb; 4(2):e210235. PubMed ID: 33635327
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic stewardship teams and
Vaughn VM; Greene MT; Ratz D; Fowler KE; Krein SL; Flanders SA; Dubberke ER; Saint S; Patel PK
Infect Control Hosp Epidemiol; 2020 Feb; 41(2):143-148. PubMed ID: 31806059
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial Stewardship and the Infection Control Practitioner: A Natural Alliance.
Zhou S; Nagel JL; Kaye KS; LaPlante KL; Albin OR; Pogue JM
Infect Dis Clin North Am; 2021 Sep; 35(3):771-787. PubMed ID: 34362543
[TBL] [Abstract][Full Text] [Related]
8. Comparing intervention strategies for reducing Clostridioides difficile transmission in acute healthcare settings: an agent-based modeling study.
Stephenson B; Lanzas C; Lenhart S; Ponce E; Bintz J; Dubberke ER; Day J
BMC Infect Dis; 2020 Oct; 20(1):799. PubMed ID: 33115427
[TBL] [Abstract][Full Text] [Related]
9. Sustained reductions in unnecessary antimicrobial administration and hospital
Gaffin N; Spellberg B
Infect Control Hosp Epidemiol; 2023 Mar; 44(3):491-493. PubMed ID: 34915961
[TBL] [Abstract][Full Text] [Related]
10. Effects of Antibiotic Cycling Policy on Incidence of Healthcare-Associated MRSA and Clostridioides difficile Infection in Secondary Healthcare Settings.
Conlon-Bingham GM; Aldeyab M; Scott M; Kearney MP; Farren D; Gilmore F; McElnay J
Emerg Infect Dis; 2019 Jan; 25(1):52-62. PubMed ID: 30561306
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
[No Abstract] [Full Text] [Related]
12. The cost-benefit of federal investment in preventing Clostridium difficile infections through the use of a multifaceted infection control and antimicrobial stewardship program.
Slayton RB; Scott RD; Baggs J; Lessa FC; McDonald LC; Jernigan JA
Infect Control Hosp Epidemiol; 2015 Jun; 36(6):681-7. PubMed ID: 25783204
[TBL] [Abstract][Full Text] [Related]
13. Problems of
Kiersnowska Z; Lemiech-Mirowska E; Ginter-Kramarczyk D; Kruszelnicka I; Michałkiewicz M; Marczak M
Ann Agric Environ Med; 2021 Jun; 28(2):224-230. PubMed ID: 34184502
[TBL] [Abstract][Full Text] [Related]
14. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?
Hawes AM; Desai A; Patel PK
Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702
[TBL] [Abstract][Full Text] [Related]
15. The economic burden of Clostridium difficile.
McGlone SM; Bailey RR; Zimmer SM; Popovich MJ; Tian Y; Ufberg P; Muder RR; Lee BY
Clin Microbiol Infect; 2012 Mar; 18(3):282-9. PubMed ID: 21668576
[TBL] [Abstract][Full Text] [Related]
16. Modeling inpatient and outpatient antibiotic stewardship interventions to reduce the burden of Clostridioides difficile infection in a regional healthcare network.
Rhea S; Jones K; Endres-Dighe S; Munoz B; Weber DJ; Hilscher R; MacFarquhar J; Sickbert-Bennett E; DiBiase L; Marx A; Rineer J; Lewis J; Bobashev G;
PLoS One; 2020; 15(6):e0234031. PubMed ID: 32525887
[TBL] [Abstract][Full Text] [Related]
17. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM
Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595
[TBL] [Abstract][Full Text] [Related]
18. Defining the decision problem: a scoping review of economic evaluations for Clostridioides difficile interventions.
Richardson M; Erman A; Daneman N; Miller FA; Sander B
J Hosp Infect; 2022 Mar; 121():22-31. PubMed ID: 34813872
[TBL] [Abstract][Full Text] [Related]
19. Strategies to prevent adverse outcomes following
Rauseo AM; Olsen MA; Reske KA; Dubberke ER
Expert Rev Anti Infect Ther; 2020 Mar; 18(3):203-217. PubMed ID: 31976779
[No Abstract] [Full Text] [Related]
20. Societal willingness to pay to avoid mortality and morbidity from Clostridioides difficile and carbapenem-resistant Enterobacteriaceae infections in the United States.
Sertkaya A; Wong HH; Ertis DH; Jessup A
Am J Infect Control; 2019 May; 47(5):521-526. PubMed ID: 30579590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
